Alnylam Pharmaceuticals, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/3/2026 | 6,310 | 0.0% | 15,869 | 12/31/2025 |
| 2025 Q3 | 10/24/2025 | 7,217 | 0.1% | 15,826 | 9/30/2025 |
| 2025 Q2 | 7/10/2025 | 4,829 | 0.0% | 14,808 | 6/30/2025 |
| 2025 Q1 | 4/28/2025 | 3,499 | 0.0% | 12,957 | 3/31/2025 |
| 2024 Q4 | 1/28/2025 | 2,732 | 0.0% | 11,611 | 12/31/2024 |
| 2024 Q3 | 10/17/2024 | 3,185 | 0.0% | 11,581 | 9/30/2024 |
| 2024 Q2 | 7/30/2024 | 2,944 | 0.0% | 12,114 | 6/30/2024 |
| 2024 Q1 | 5/2/2024 | 1,419 | 0.0% | 9,495 | 3/31/2024 |
| 2023 Q4 | 2/1/2024 | 1,823 | 0.0% | 9,523 | 12/31/2023 |
| 2023 Q3 | 10/30/2023 | 1,687 | 0.0% | 9,523 | 9/30/2023 |
| 2023 Q2 | 8/4/2023 | 1,814 | 0.0% | 9,549 | 6/30/2023 |
| 2023 Q1 | 5/2/2023 | 1,661 | 0.0% | 8,290 | 3/31/2023 |
| 2022 Q4 | 1/26/2023 | 1,970 | 0.0% | 8,290 | 12/31/2022 |
| 2022 Q3 | 10/19/2022 | 1,659 | 0.0% | 8,290 | 9/30/2022 |
| 2022 Q2 | 7/13/2022 | 1,037 | 0.0% | 7,112 | 6/30/2022 |
| 2022 Q1 | 4/19/2022 | 1,161 | 0.0% | 7,112 | 3/31/2022 |
| 2021 Q4 | 1/20/2022 | 1,211 | 0.0% | 7,146 | 12/31/2021 |
| 2021 Q3 | 10/15/2021 | 1,123 | 0.0% | 5,949 | 9/30/2021 |
| 2021 Q2 | 7/19/2021 | 1,022 | 0.0% | 6,029 | 6/30/2021 |
| 2021 Q1 | 5/7/2021 | 855 | 0.0% | 6,057 | 3/31/2021 |
| 2020 Q4 | 2/2/2021 | 786 | 0.0% | 6,055 | 12/31/2020 |
| 2020 Q3 | 10/29/2020 | 881 | 0.0% | 6,055 | 9/30/2020 |
| 2020 Q2 | 8/12/2020 | 896 | 0.0% | 6,055 | 6/30/2020 |
| 2020 Q1 | 4/21/2020 | 658 | 0.0% | 6,048 | 3/31/2020 |
| 2019 Q4 | 1/24/2020 | 692 | 0.0% | 6,013 | 12/31/2019 |